Immunic, Inc. Share-based Payment Arrangement, Accelerated Cost
Immunic, Inc. (IMUX) reported Share-based Payment Arrangement, Accelerated Cost of $1.20 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost · last filed 2026-02-26
- Immunic, Inc. share-based payment arrangement, accelerated cost for the quarter ending 2025-12-31 was $0.00.
- Immunic, Inc. share-based payment arrangement, accelerated cost for the quarter ending 2025-09-30 was $0.00.
- Immunic, Inc. share-based payment arrangement, accelerated cost for the quarter ending 2025-06-30 was $0.00.
- Immunic, Inc. share-based payment arrangement, accelerated cost for the quarter ending 2025-03-31 was $1.20M, a 0.00% change year-over-year.
- Immunic, Inc. share-based payment arrangement, accelerated cost for fiscal 2025 was $1.20M.
| Period end | Share-based Payment Arrangement, Accelerated Cost 3 month | Share-based Payment Arrangement, Accelerated Cost 6 month | Share-based Payment Arrangement, Accelerated Cost 9 month | Share-based Payment Arrangement, Accelerated Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $1.20M 10-K · filed 2026-02-26 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $1.20M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.20M 10-Q · filed 2025-08-07 | ||
| 2025-03-31 | $1.20M 10-Q · filed 2025-05-15 | |||
| 2024-03-31 | $1.20M 10-Q · filed 2024-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B |